Cardiovascular disease, with atherosclerosis as the major underlying factor, remains the
leading cause of death worldwide. It is well established that cholesterol ester-enriched foam …

Several prospective epidemiological studies have shown that there is a clear inverse
relationship between serum high-density lipoprotein-cholesterol (HDL-C) concentrations …

Diabetes, the ninth leading cause of death globally, is expected to affect 642 million people
by 2040. With the advancement of an aging society, the number of patients with diabetes …

Diabetes-associated morbidity and mortality is predominantly due to complications of the
disease that may cause debilitating conditions, such as heart and renal failure, hepatic …

Lipids and lipoproteins, their metabolism, and their transport are essential contributing
factors of cardiovascular disease (CVD) as they regulate plasma cholesterol concentration …

In patients with diabetes, myocardial fibrosis may contribute to the pathogenesis of heart
failure and arrhythmogenesis, increasing ventricular stiffness and delaying conduction …

Advanced glycation end-products are a complex and heterogeneous group of compounds
that have been implicated in diabetes related complications. At present it is not known if they …

Diabetes mellitus is a common endocrine disorder characterised by hyperglycaemia and
predisposes to chronic complications affecting the eyes, blood vessels, nerves and kidneys …

Dyslipidemia, characterized by a high level of lipids (cholesterol, triglycerides, or both), can
increase the risk of develo** and progressing atherosclerosis. As atherosclerosis …

Background Diabetes mellitus (DM) is a major public health problem which prevalence is
constantly raising, particularly in low-and middle-income countries. Both diabetes mellitus …